| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.7 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.097 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |